4.10k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies.
Curated by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies. These companies develop specialty drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.
The list includes stocks priced at $5 or more with a three month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
This watchlist is similar to a discontinued watchlist called Battling Cancer.
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.How are these weighted?
The stocks in this watchlist are weighted equally.
|Watchlist||Change today||1-month return||1-year return||Total return|
|Biotech and Drug Stocks||-1.07%||-||-||-|
|Symbol||Company name||Last price||Change||% change||Market time||Volume||Avg vol (3-month)||Market cap|
|JNJ||Johnson & Johnson||164.96||-2.12||-1.27%||4:00 pm GMT-4||7.39M||7.18M||434.41B|
|RHHBY||Roche Holding AG||47.56||-0.22||-0.46%||3:59 pm GMT-4||2.12M||1.46M||330.24B|
|PFE||Pfizer Inc.||40.15||-0.53||-1.30%||4:02 pm GMT-4||20.61M||27.62M||224.75B|
|LLY||Eli Lilly and Company||224.09||-9.45||-4.05%||4:02 pm GMT-4||5.55M||3.66M||214.91B|
|NVS||Novartis AG||92.69||-0.81||-0.87%||4:00 pm GMT-4||1.37M||1.88M||209.06B|
|ABBV||AbbVie Inc.||115.42||-0.82||-0.71%||4:02 pm GMT-4||4.01M||7.02M||203.86B|
|NVO||Novo Nordisk A/S||84.45||-0.31||-0.37%||4:00 pm GMT-4||786.14k||886.85k||194.29B|
|MRK||Merck & Co., Inc.||76.27||+0.13||+0.17%||4:02 pm GMT-4||12.86M||12.97M||193.12B|
|AZN||AstraZeneca PLC||58.77||-0.07||-0.12%||4:00 pm GMT-4||7.68M||8.57M||155.11B|
|BMY||Bristol-Myers Squibb Company||67.34||-0.05||-0.07%||4:00 pm GMT-4||9.54M||10.91M||150.36B|
|AMGN||Amgen Inc.||242.77||-1.87||-0.76%||4:00 pm GMT-4||2.00M||2.79M||139.48B|
|SNY||Sanofi||53.8||+0.02||+0.04%||4:00 pm GMT-4||871.61k||1.26M||135.34B|
|GSK||GlaxoSmithKline plc||40.15||-0.08||-0.20%||4:00 pm GMT-4||2.86M||4.68M||100.04B|
|MRNA||Moderna, Inc.||218.85||+1.85||+0.85%||4:00 pm GMT-4||5.58M||9.54M||87.87B|
|ZTS||Zoetis Inc.||182.2||+0.10||+0.05%||4:03 pm GMT-4||1.60M||1.79M||86.50B|
|GILD||Gilead Sciences, Inc.||68.77||-0.52||-0.75%||4:00 pm GMT-4||6.91M||7.24M||86.25B|
|BAYRY||Bayer Aktiengesellschaft||16.26||+0.05||+0.31%||3:57 pm GMT-4||196.62k||396.76k||63.94B|
|BIIB||Biogen Inc.||396.64||-18.07||-4.36%||4:00 pm GMT-4||4.22M||1.72M||59.72B|
|BNTX||BioNTech SE||238.55||-1.27||-0.53%||4:00 pm GMT-4||1.12M||2.90M||57.61B|
|REGN||Regeneron Pharmaceuticals, Inc.||525.55||-6.49||-1.22%||4:00 pm GMT-4||623.06k||828.13k||55.99B|
|TAK||Takeda Pharmaceutical Company Limited||17.21||-0.15||-0.86%||4:00 pm GMT-4||1.25M||2.42M||54.45B|
|VRTX||Vertex Pharmaceuticals Incorporated||193.02||-23.75||-10.96%||4:00 pm GMT-4||13.73M||1.81M||49.97B|
|ALXN||Alexion Pharmaceuticals, Inc.||181.65||-0.34||-0.19%||4:00 pm GMT-4||1.31M||2.13M||40.15B|
|SGEN||Seagen Inc.||156.58||-1.90||-1.20%||4:00 pm GMT-4||481.32k||932.72k||28.42B|
|GMAB||Genmab A/S||43.74||+0.11||+0.25%||4:00 pm GMT-4||612.63k||462.43k||28.34B|
|RPRX||Royalty Pharma plc||44.9||-1.73||-3.71%||4:00 pm GMT-4||2.34M||2.43M||27.26B|
|HZNP||Horizon Therapeutics Public Limited Company||93.29||-0.66||-0.70%||4:00 pm GMT-4||1.20M||1.62M||20.97B|
|ALNY||Alnylam Pharmaceuticals, Inc.||165.02||+1.76||+1.08%||4:00 pm GMT-4||709.35k||502.53k||19.40B|
|VTRS||Viatris Inc.||15.73||-0.06||-0.38%||4:00 pm GMT-4||4.13M||9.42M||19.01B|
|CTLT||Catalent, Inc.||109.05||+0.18||+0.17%||4:02 pm GMT-4||489.10k||1.08M||18.58B|
Bristol Myers Squibb (NYSE: BMY) recently picked up another U.S. Food and Drug Administration (FDA) approval for Zeposia in treating ulcerative colitis. In this Motley Fool Live video recorded on June 2, Motley Fool contributors Keith Speights and Brian Orelli discuss just how big this FDA win is for Bristol Myers Squibb.
The EMA considers the vaccine safe for all age groups, and has been clear in its advice that the benefits of taking the vaccine outweigh the risks, however some member states have restricted its use in the older population.
Biogen (NASDAQ: BIIB) investors cheered earlier this week after the biotech company scored a major regulatory victory. The U.S. Food and Drug Administration approved its controversial Alzheimer's drug. Now, some investors are wondering whether it's too late to get in on the Biogen story.